by Dual chamber prefilled syringes provide an advanced method for delivery of two distinct drugs or drug formulations from a single device. These syringes contain a central barrier to separate the different drug components in two chambers within the barrel. This barrier can be pierced, broken or removed to allow the drugs to mix prior to injection. Dual chamber prefilled syringes offer various advantages over traditional prefilled syringes such as accurate mixing of drugs, simplified administration, decreased risk of dosing errors and improved stability of drugs. They are highly preferred for delivery of drugs that undergo chemical reactions when mixed. The increasing demand for delivery of biologics and biosimilars is a major factor driving the use of dual chamber prefilled syringes.
The Global dual chamber prefilled syringes Market is estimated to be valued at US$ 171.8 Mn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the dual chamber prefilled syringes are Pfizer Inc., NIPRO PHARMA CORPORATION, Gerresheimer AG, Vetter Pharma, Credence MedSystems, Inc., ARTE Corporation, BD, MAEDA INDUSTRY Co., Ltd., Bayer, Stevanato Group, Elcam Drug Delivery Devices, SCHOTT Pharma, OndrugDelivery Ltd, Catalent, Inc, Dätwyler Holding Inc.
The Dual Chamber Prefilled Syringes Market Size offers significant opportunities such as increased research and development of vaccines that require storage of liquid and lyophilized components separately. Technological advancements such as development of auto mixing systems that ensures optimal mixing of components are boosting the dual chamber prefilled syringes market growth.
Market Drivers
The increasing demand for delivery of biologics such as monoclonal antibodies, recombinant proteins and vaccines is a major market driver. Many biologics are temperature sensitive and dual chamber prefilled syringes help extend their shelf life. Growing prevalence of chronic diseases worldwide is also driving the need for drugs with complex dosing requirements that can be better delivered through dual chamber prefilled syringes. Rise in clinical research for development of new drugs is augmenting the demand. Regulatory support and approvals for user-friendly drug delivery devices further support the market growth.
Current challenges faced by the dual chamber prefilled syringes industry
The Dual Chamber Prefilled Syringes Market Size is facing challenges in terms of maintaining sterility while manufacturing prefilled syringes on a large scale. Proper sterilization techniques need to be followed to avoid contamination. Maintaining stability of biologics also poses a challenge as some biologics tend to degrade or denature when exposed to light, heat, moisture, or agitation. Another challenge is ensuring reliability in terms of preventing mixing of the drug and diluent compartments until activation. Accurately filling and sealing very small volumes in a way that prevents leakage during transportation and storage is difficult. Stringent regulations also need to be complied with to market medical devices and pharmaceutical products.
SWOT Analysis
Strength: Dual chamber prefilled syringes offer benefits of stability, ease of administration and dose accuracy. They provide maximum protection and extend shelf life of drugs.
Weakness: Increased complexity in design and manufacturing compared to conventional syringes. More chances of leaking at the sealing area.
Opportunity: Growing biologics market and self-injection trend create huge opportunities. Prefilled syringes prevent medication errors and improve patient compliance.
Threats: Entry of new players increases competition. Supply chain and sourcing issues during pandemic threaten consistent supply.
North America accounts for the largest share in the dual chamber prefilled syringes market currently due to presence of major players and rising demand for self-administered drug delivery devices. North America is followed by Europe and Asia Pacific region.
China, India and other Southeast Asian countries together form the fastest growing regional market for dual chamber prefilled syringes. Increasing healthcare expenditure, large patient pool, rise in lifestyle diseases and greater acceptance of self-administration are driving higher adoption of prefilled syringes in Asia Pacific region.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
